Cspc zhongqi pharmaceutical
WebCSPC has a leading R&D team of more than 2,000 people in China with over 200 talents with doctorate or overseas experience. Research and development bases are located in Shijiazhuang, Shanghai, Beijing and the United States, focusing on the discovery, research and development of small molecule target drugs, nano-drugs, monoclonal antibody … WebCSPC WEISHENG PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. was founded on May 18, 1994, and its manufacturing plant was formally put into operation in early 1996. It is a …
Cspc zhongqi pharmaceutical
Did you know?
WebDec 28, 2024 · SYHA 1807 is a lysine specific demethylase 1 (LSD1) inhibitor, being developed by CSPC Zhongqi Pharmaceutical Technology, in collaboration with WuXi … WebFeb 25, 2024 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ClinicalTrials.gov Identifier: NCT03852823 Other Study ID Numbers: SG001202401 : First Posted: …
WebApr 10, 2024 · FE-SYHA1402: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ZhongQi Pharmaceutical Technology is conducting a multiple doses study to evaluate the safety, tolerability, pharmacokinetics (including food effect) of SYHA1402 in healthy subjects. This study consists of two parts: The objective of the food effect study (Part 1) … WebCompany profile page for CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd including stock price, company news, press releases, executives, board members, and …
WebCSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of … WebNov 15, 2024 · Xue:CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd: Current Employment. Wang:CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd: Current Employment. Xie:CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd: Current Employment. Li:CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd: Current …
WebKey Products. Finished drugs. Bulk drugs. NBP (soft capsules) NBP (injections) Oulaining (capsules) Oulaining (lyophilised powder for injections) Enxi. NBP (soft capsules) Headquarters; Address: No.226 Huanghe Street, Shijiazhuang, Hebei Province, … As at 31 December : 2024 RMB'000 (Restated) 2024 RMB'000 (Restated) … For 2024 Annual Results. Sales of approximately RMB30,937 million, … 2024 Annual Results Announcement. Mar. 22 CPSC has set up a centralized quality control department which is responsible … CSPC aspires to become health messengers for the majority of patients, … CSPC Pharmaceutical Announces 2024 Interim Results, Profit Attributable to …
WebJul 1, 2024 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (Industry) Overall Status. Unknown status. CT.gov ID NCT04453618. Collaborator (none) 42. Enrollment. 4. Arms. 4. Anticipated Duration (Months) Study Details Study Description Brief Summary. A Multiple Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Including … hiuskasku heinävesiWebThe present invention relates to a method for resolution of a mixture of pinocembrin optical isomers, in particular a pinocembrin racemate, using a chiral primary amine or a chiral sulfinamide. The present invention also relates to a (R) … hius kauneushoitolaWebOct 12, 2024 · In September 2024, Celltrion agreed to jointly develop Abpro’s cancer molecule ABP-102 in a deal that could be worth as much as $1.75 billion.Massachusetts-based Abpro is developing ABP-102 as ... hiuskeskus kokkolaWebJan 14, 2024 · FE-SYHA1402 by CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ZhongQi Pharmaceutical Technology is conducting a multiple doses study to assess … hiuskeskus milla marika kokkolaWebCSPC ZhongQi Pharmaceutical Technology Co Ltd For information regarding COVID-19 clinical trials, please visit www.covid19studies.org or click here . Log In / Sign Up hius kauneushoitola jyväskyläWebCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as … hiuskimallusWebCSPC ZhongQi Pharmaceutical Technology Co., Ltd SYS6006 Walvax Biotechnology Co., Ltd. Shanghai RNACure Biopharma Co., Ltd. RQ3013 ... Ningbo Rongan Biological Pharmaceutical Co. Ltd; First Affiliated Hospital Bengbu Medical College LVRNA012 COVID-19 (Omicron) hiuskiinnike